Excedrin Migraine Full Migraine Indication Approved By FDA
This article was originally published in The Tan Sheet
Executive Summary
Bristol-Myers Squibb's Excedrin Migraine indication for full migraine syndrome was approved by FDA Oct. 7. The new labeling simply bears the indication "Treats migraine."